fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

How should advanced therapies be classified?

Written by | 14 Jun 2012

Emerging uses of EMA Approved Drugs – by Gary Finnegan – The EMA has launched a public consultation on the classification of advanced therapies.

Genes increases risk of osteoporosis fractures

Written by | 14 Jun 2012

World Health Matters (Sweden) – by Gary Finnegan – Scientists in Sweden believe that have identified a set of genetic variations which cause osteoporosis.

Children with cancer have complete responses in a Children’s Oncology Group phase 1 trial

Written by | 12 Jun 2012

Pictured: Dr. Yael P. Mosse is a pediatric oncologist at The Children’s Hospital of Philadelphia.  Children’s Hospital of Philadelphia researcher leads trial of ALK inhibitor in neuroblastoma, lymphoma. … read more.

Researchers discover potential cause of chronic painful skin

Written by | 11 Jun 2012

Skin cell target for pain discovered using novel translational research platform.

SABCS 2011 Report – Environmental and lifestyle influences on the development of breast cancer

Written by | 14 May 2012

by Dr Sunil Upadhyay – Breast cancer is one of the most common malignancies in women all over the world and its complex and multi-factorial aetiology remains unclear…. read more.

AACE endorses new lower LDL targets and ApoB testing

Written by | 2 May 2012

New guidelines on dyslipidemia and the prevention of atherogenesis give official sanction to something endocrinologists have been doing for years: lowering LDL targets.

ESMO 2011 Report – How safe is chemotherapy during pregnancy?

Written by | 16 Apr 2012

by Dr Sunil Upadhyay – The overall incidence of cancer is known to increase with age. However, there is hardly any age group that can be spared from… read more.

ESMO 2011 Report – Shaping the future: from principle to practice

Written by | 16 Apr 2012

by Dr Sunil Upadhyay – One of the most important advances in cancer research over the last decade or so has been the appearance of targeted therapies. It… read more.

BTS 2012 Report – Pathways of MHC Allorecognition

Written by | 28 Mar 2012

by Maria Dalby reporting on the presentation by Robert Lechler, King’s College Hospital, London.  Understanding how a transplant recipient’s immune system recognises the alloantigens that trigger rejection is… read more.

Multiple sclerosis research doubles number of genes associated with the disease

Written by | 16 Mar 2012

Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of this very debilitating neurological disease. Many of the genes –… read more.

Research proving link between virus and MS could point the way to treatment and prevention

Written by | 16 Mar 2012

A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in… read more.

IASLC 2011 Report – Defining the unmet needs in non-small cell lung cancer

Written by | 18 Jan 2012

by Dr Sunil Upadhyay – The way we have defined cancer has not changed over centuries. Most of the lung cancers are associated with smoking. There is plenty… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.